Dr. James Yao
VIENNA – The mTOR inhibitor everolimus cut the risk of progression or death by 52% for patients with advanced,... More
Gov. Jerry Brown
California Gov. Jerry Brown (D) has signed into law a controversial measure that allows physicians to help terminally... More
Dr. Philippe Ruszniewski
VIENNA – After posting unprecedented results in the phase III NETTER-1 trial, the experimental radiopeptide therapy... More
Dr. Michael J. Silverberg
The cumulative rates of anal, colorectal, and liver cancers are increasing among HIV-positive patients, mainly because... More
GAO: Physicians, hospitals struggle to achieve EHR interoperability
Physicians and health care organizations are struggling to achieve interoperability, the exchange of data between their... More
FDA approves pembrolizumab for advanced NSCLC
The Food and Drug Administration has granted accelerated approval for pembrolizumab to treat patients with metastatic... More
Dr. John G. Gribben
CHICAGO – Consider using novel agents in chronic lymphocytic leukemia (CLL) patients who are refractory to treatment or... More
Chromosome 3 abnormalities linked to poor CML outcomes
Chromosome 3 abnormalities, specifically 3q26.2 rearrangements, were associated with treatment resistance and poor... More
FDA approves nivolumab-ipilimumab combination for melanoma
Nivolumab, a programmed death receptor-1 (PD-1)–blocking antibody, has been approved for use in combination with... More
Narrow-band colonoscopy faster, as sensitive as white light in ulcerative colitis
Among patients with ulcerative colitis (UC), narrow-band imaging colonoscopy with targeted and segmental biopsy... More
Dr. John G. Gribben
CHICAGO – The majority of patients with chronic lymphocytic leukemia (CLL) are elderly patients over age 65 years,... More
Dr. Ann Banke
LONDON – Adult patients with chronic heart failure had an average 51% increased incidence of all forms of cancer,... More
Dr. David Rimm
DENVER – In patients with non–small cell lung cancer (NSCLC), the programmed death-ligand 1 (PD-L1) status of the... More
Dr. Brittany L. Murphy
SAN FRANCISCO – Nipple-sparing mastectomy can be a safe surgical option for carefully selected patients with... More
Shorter colonoscopies tied to higher colorectal cancer rates
Risk of interval colorectal cancer (CRC) more than doubled when average withdrawal times during routine colonoscopy... More
Fukuoka, Sendai guidelines identified advanced pancreatic neoplasias
Both the Sendai and Fukuoka guidelines correctly identified all patients whose cystic pancreatic lesions were advanced... More
Reduced-nicotine cigarettes cut dependence, smoking
Reduced-nicotine cigarettes decreased tobacco dependence and the number of cigarettes smoked, with very little evidence... More
Dr. Tanir Allweis
SAN FRANCISCO – Breast density is an independent risk factor for positive lumpectomy margins, pointing to a need for... More
A wide spectrum of legal dangers can arise from telemedicine, including malpractice and product liability claims, data exposure, and credentialing risks.... More »
VIENNA – The mTOR inhibitor everolimus cut the risk of progression or death by 52% for patients with advanced, progressive, nonfunctional lung or gastrointestinal neuroendocrine tumors in RADIANT-4. Median progression-free survival (PFS) by centra... More »
Concerns about surgical morbidity may favor laparoscopic approaches to rectal cancer surgery, but pathology results suggest open procedures produce more successful resections.... More »
California Gov. Jerry Brown signed into law a controversial measure that allows physicians to help patients legally end their lives.... More »
The experimental radiopeptide therapy 177Lu-Dotatate looks poised to become a new treatment option for patients with midgut neuroendocrine tumors that progress on somatostatin analogues.... More »
The cumulative rates of anal, colorectal, and liver cancers are increasing among HIV-positive patients, mainly because in the antiretroviral era they are living long enough for these malignancies to develop.... More »
While vulvar cancer is a rare gynecologic malignancy, it can be devastating for patients and families, especially at late stages. Early diagnosis and treatment is imperative for improved patient outcomes. An increased awareness among patients and phy... More »
With the race to develop cancer immunotherapies escalating and new agents appearing in the clinic, oncologists’ decision-making toolbox will need to evolve. “As immunotherapeutics become increasingly available to patients, clinicians face a majo... More »
S.Y. TAN, M.D.
Question: Which of the following statements regarding statutory caps on malpractice damages is best? A. All states have such a statutory provision. B. The provision limits the recovery of both economic and noneconomic losses. C. It’s constitutio... More »
Transparency, until recently, was rarely associated with health care. Not anymore. For better and sometimes worse, there is a revolutionary movement toward transparency in all facets of health care: transparency of costs, outcomes, quality, service, ... More »
Too many clinicians struggle with systems and describe data that reflect things they have not done, all due to the use of EHR default settings that have never been changed.... More »
S.Y. TAN, M.D., J.D.
A shift toward a patient-oriented requisite standard of disclosure is changing the risk to physicians posed by informed consent.... More »